Suppliers / Chengdu Sino-Strong Pharmaceutical

Chengdu Sino-Strong Pharmaceutical

China Updated 9 July 2026

Chengdu Sino-Strong Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
China, China 3014769475

What they file, and where

Molecule Regulators Docs
Parecoxib US FDA 1
Rocuronium US FDA 1

Also appears on these molecule pages

Rocuronium API

Questions about Chengdu Sino-Strong Pharmaceutical

Does Chengdu Sino-Strong Pharmaceutical hold a US DMF or a CEP?
Chengdu Sino-Strong Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Chengdu Sino-Strong Pharmaceutical FDA-registered?
One site operated by Chengdu Sino-Strong Pharmaceutical carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Chengdu Sino-Strong Pharmaceutical manufacture?
1 registered site is on record, in China (China). Every site is listed on this page with the register it came from.
What does Chengdu Sino-Strong Pharmaceutical make?
2 molecules are on record against Chengdu Sino-Strong Pharmaceutical, including Parecoxib and Rocuronium. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Chengdu Sino-Strong Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Zhejiang Huahai Pharmaceutical shares 1 molecule Wavelength Enterprises shares 1 molecule Curia shares 1 molecule Gland Pharma shares 1 molecule Mankind Pharma shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability